By J. Todd Weber

Combating, controlling and treating drug-resistant infections is without doubt one of the significant demanding situations in smooth medication. "Antimicrobial Resistance" is going past uncomplicated definitions and microbiological information to completely discover this quickly altering zone, describing proof for powerful interventions, expenditures, therapy concepts and instructions for destiny study. every one bankruptcy presents crucial heritage and examines the facts for a major element of prevention and regulate, remedy approach or coverage choice. Prevention and regulate options are analyzed for beside the point antimicrobial use, fluoroquinolone-resistant organisms, health-care linked infections and parasitic illnesses. in addition, remedy options for altering resistance styles are explored for community-acquired pneumonia in the course of an influenza pandemic and infections with community-associated MRSA, extended-spectrum beta-lactamase generating organisms and fungi. facts for coverage making are provided in articles that aspect the prices of antimicrobial-resistant infections in healthcare settings and the specter of resistance with the advent of antiretroviral remedy for giant populations within the constructing global. those stories exhibit the place interventions, surveillance and learn may be most dear sooner or later. "Antimicrobial Resistance" is a useful contribution for infectious affliction physicians and public overall healthiness officers who're attracted to the prevention of antimicrobial-resistant infections.

Show description

Read or Download Antimicrobial Resistance: Beyond the Breakpoint (Issues in Infectious Diseases) PDF

Similar infectious disease books

Antifungal Agents: Methods And Protocols (Methods in Molecular Medicine)

A suite of state of the art molecular equipment for learning antifungal resistance, for locating and comparing either new and latest antifungal medicines, and for figuring out the host reaction and immunotherapy of such brokers. The protocols stick to the profitable equipment in Molecular medication™ sequence layout, each one providing step by step laboratory directions, an advent outlining the main at the back of the strategy, lists of the mandatory gear and reagents, and pointers on troubleshooting and fending off recognized pitfalls.

The Official Patient's Sourcebook on Swimmer's Itch: A Revised and Updated Directory for the Internet Age

This sourcebook has been created for sufferers who've made up our minds to make schooling and Internet-based study an essential component of the therapy technique. even though it supplies info priceless to medical professionals, caregivers and different wellbeing and fitness pros, it additionally tells sufferers the place and the way to appear for info masking almost all themes concerning swimmer's itch, from the necessities to the main complicated parts of analysis.

Additional resources for Antimicrobial Resistance: Beyond the Breakpoint (Issues in Infectious Diseases)

Sample text

Assess whether the patient is truly infected or is merely colonized 2. If colonized, no therapy is indicated (infection control interventions may be relevant) 3. If infected, carbapenems are the therapy of choice: (a) meropenem or imipenem for initial therapy of bloodstream infections, hospital-acquired pneumonia or intra-abdominal infections (b) ertapenem for complicated urinary tract infections, for infections managed within nursing homes, streamlined hospital therapy and parenteral outpatient therapy 4.

65 Brun-Buisson C, Legrand P, Rauss A, et al: Intestinal decontamination for control of nosocomial multiresistant Gram-negative bacilli: study of an outbreak in an intensive care unit. Ann Intern Med 1989;110: 873–881. 66 Taylor ME, Oppenheim BA: Selective decontamination of the gastrointestinal tract as an infection control measure. J Hosp Infect 1991;17:271–278. 67 Paterson DL, Singh N, Rihs JD, Squier C, Rihs BL, Muder RR: Control of an outbreak of infection due to extended-spectrum beta-lactamase-producing Escherichia coli in a liver transplantation unit.

A classification of fluoroquinolones for use in humans Quinolone Current usage First Generation Nalidixic acid limited Second Generation Norfloxacin Ciprofloxacin Ofloxacin Enoxacin Fleroxacin Pefloxacin Lomefloxacin limited widespread limited limited limited limited limited Third generation Levofloxacin Gatifloxacin Grepafloxacin Sparfloxacin Temafloxacin widespread widespread in certain countries withdrawn withdrawn withdrawn Fourth generation Moxifloxacin Gemifloxacin Trovafloxacin widespread limited withdrawn C-6 position and piperanzinyl or related ring at position C-7 of the quinolone molecule resulted in the fluoroquinolone group with broader activity, and these became available in the 1980s (table 1).

Download PDF sample

Rated 4.49 of 5 – based on 41 votes